Literature DB >> 20521150

[Is intraoperative ICD-testing still necessary?].

C Mewis1, H-R Neuberger, A Buob.   

Abstract

Intraoperative ICD-testing is traditionally performed in many hospitals in order to ensure reliable sensing, detection, and defibrillation of induced ventricular fibrillation. The technical progress of defibrillators allows rapid detection and delivery of high energy shocks which defibrillates effectively in the vast majority all patients at implant. This review describes arguments pro and contra of systematic testing of the defibrillation threshold in all patients. Many reasons argue against testing in all patients: experimental considerations, patients' specific and nonspecific factors, e.g., underlying severity of cardiac disease, ischemia, and medication, as well as factors specific to the ICD system, e.g., implanted type and location of electrodes and active cans. Finally, the testing method is very important, since it bears the risk of false negative test results because the a priori probability of a positive test result is >95%. Therefore, data from prospective randomized studies are necessary in order to abandon the tradition of ICD-testing on an evidence-based background.

Entities:  

Mesh:

Year:  2010        PMID: 20521150     DOI: 10.1007/s00399-010-0080-3

Source DB:  PubMed          Journal:  Herzschrittmacherther Elektrophysiol        ISSN: 0938-7412


  34 in total

1.  Defibrillation testing at the time of implantation of cardioverter defibrillator in the clinical practice: a nation-wide survey.

Authors:  Michele Brignole; Giovanni Raciti; Maria Grazia Bongiorni; Giuseppe De Martino; Stefano Favale; Maurizio Gasparini; Raffaele Luise; Eraldo Occhetta; A Proclemer
Journal:  Europace       Date:  2007-05-16       Impact factor: 5.214

2.  Effect of amiodarone and sotalol on ventricular defibrillation threshold: the optimal pharmacological therapy in cardioverter defibrillator patients (OPTIC) trial.

Authors:  Stefan H Hohnloser; Paul Dorian; Robin Roberts; Michael Gent; Carsten W Israel; Eric Fain; Jean Champagne; Stuart J Connolly
Journal:  Circulation       Date:  2006-07-03       Impact factor: 29.690

3.  High defibrillation thresholds in transvenous biphasic implantable defibrillators: clinical predictors and prognostic implications.

Authors:  Himanshu H Shukla; Greg C Flaker; Vinod Jayam; David Roberts
Journal:  Pacing Clin Electrophysiol       Date:  2003-01       Impact factor: 1.976

4.  Defibrillation threshold testing: is it really necessary at the time of implantable cardioverter-defibrillator insertion?

Authors:  Andrea M Russo; William Sauer; Edward P Gerstenfeld; Henry H Hsia; David Lin; Joshua M Cooper; Sanjay Dixit; Ralph J Verdino; Hemal M Nayak; David J Callans; Vickas Patel; Francis E Marchlinski
Journal:  Heart Rhythm       Date:  2005-05       Impact factor: 6.343

5.  Sudden death in patients with implantable cardioverter defibrillators: the importance of post-shock electromechanical dissociation.

Authors:  L Brent Mitchell; Edgar A Pineda; Jack L Titus; Paulette M Bartosch; David G Benditt
Journal:  J Am Coll Cardiol       Date:  2002-04-17       Impact factor: 24.094

6.  Long-term clinical course of patients after termination of ventricular tachyarrhythmia by an implanted defibrillator.

Authors:  Arthur J Moss; Henry Greenberg; Robert B Case; Wojciech Zareba; W Jackson Hall; Mary W Brown; James P Daubert; Scott McNitt; Mark L Andrews; Adam D Elkin
Journal:  Circulation       Date:  2004-12-06       Impact factor: 29.690

7.  Differences in the characteristics of induced and spontaneous episodes of ventricular fibrillation.

Authors:  Nigel A Lever; Emma G Newall; Peter D Larsen
Journal:  Europace       Date:  2007-09-14       Impact factor: 5.214

8.  Defibrillation threshold testing: tradition or necessity?

Authors:  Christof Kolb; Stylianos Tzeis; Bernhard Zrenner
Journal:  Pacing Clin Electrophysiol       Date:  2009-05       Impact factor: 1.976

9.  Canadian Registry of ICD Implant Testing procedures (CREDIT): current practice, risks, and costs of intraoperative defibrillation testing.

Authors:  Jeff S Healey; Paul Dorian; L Brent Mitchell; Mario Talajic; Francois Philippon; Chris Simpson; Raymond Yee; Carlos A Morillo; Andre Lamy; Magdy Basta; David H Birnie; Xiaoyin Wang; Girish M Nair; Eugene Crystal; Charles R Kerr; Stuart J Connolly
Journal:  J Cardiovasc Electrophysiol       Date:  2009-10-05

10.  Complications associated with defibrillation threshold testing: the Canadian experience.

Authors:  David Birnie; Stanley Tung; Christopher Simpson; Eugene Crystal; Derek Exner; Felix-Alejandro Ayala Paredes; Andrew Krahn; Ratika Parkash; Yaariv Khaykin; Francois Philippon; Peter Guerra; Shane Kimber; Douglas Cameron; Jeffrey S Healey
Journal:  Heart Rhythm       Date:  2007-11-28       Impact factor: 6.343

View more
  1 in total

1.  ICD implantation without intraoperative testing does not increase the rate of system modifications and does not impair defibrillation efficacy tested in follow-up.

Authors:  Dirk Bastian; Stefan Kracker; Matthias Pauschinger; Konrad Göhl
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2013-06-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.